Viemed Healthcare, Inc.
VMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $224,257 | $183,008 | $138,832 | $117,062 |
| % Growth | 22.5% | 31.8% | 18.6% | – |
| Cost of Goods Sold | $91,054 | $70,225 | $54,152 | $43,652 |
| Gross Profit | $133,203 | $112,783 | $84,680 | $73,410 |
| % Margin | 59.4% | 61.6% | 61% | 62.7% |
| R&D Expenses | $3,068 | $2,782 | $2,696 | $2,110 |
| G&A Expenses | $112,484 | $93,733 | $73,363 | $60,043 |
| SG&A Expenses | $112,484 | $93,733 | $73,363 | $60,043 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$249 | $1,938 | $369 | -$323 |
| Operating Expenses | $115,303 | $98,453 | $76,428 | $61,830 |
| Operating Income | $17,900 | $14,330 | $8,252 | $11,580 |
| % Margin | 8% | 7.8% | 5.9% | 9.9% |
| Other Income/Exp. Net | -$1,730 | $61 | $738 | $923 |
| Pre-Tax Income | $16,170 | $14,391 | $8,990 | $12,503 |
| Tax Expense | $4,761 | $4,148 | $2,768 | $3,377 |
| Net Income | $11,265 | $10,243 | $6,222 | $9,126 |
| % Margin | 5% | 5.6% | 4.5% | 7.8% |
| EPS | 0.29 | 0.27 | 0.15 | 0.23 |
| % Growth | 7.4% | 80% | -34.8% | – |
| EPS Diluted | 0.28 | 0.25 | 0.15 | 0.22 |
| Weighted Avg Shares Out | 38,755 | 38,354 | 38,655 | 39,491 |
| Weighted Avg Shares Out Dil | 40,805 | 40,379 | 39,807 | 40,681 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $776 | $424 | $197 | $318 |
| Depreciation & Amortization | $25,368 | $21,862 | $15,630 | $11,312 |
| EBITDA | $42,314 | $36,677 | $24,817 | $24,133 |
| % Margin | 18.9% | 20% | 17.9% | 20.6% |